Application for quotation of securities - ACR
Filed with ASX · · 5 pages · English
Earlier from Acrux
- Notice of Annual General Meeting/Proxy Form
- Quarterly Activities/Appendix 4C Cash Flow Report
- FDA clears regulatory pathway for Female Testosterone MDTS
- Webinar, Monday 12 October 2026 - Female Testosterone MDTS
- Acrux has received $1.977m RDTI rebate for FY26
Later from Acrux
All Acrux news releasesFollow Acrux into a list and get an email when it puts out news.
Follow Acrux